Skip to main content
Top
Published in: Clinical Rheumatology 3/2021

01-03-2021 | Systemic Sclerosis | Original Article

Intestinal hypomotility in systemic sclerosis: a histological study into the sequence of events

Authors: M. den Braber-Ymker, M. C. Vonk, K. Grünberg, M. Lammens, I. D. Nagtegaal

Published in: Clinical Rheumatology | Issue 3/2021

Login to get access

Abstract

Objectives

The pathogenesis of intestinal involvement in systemic sclerosis (SSc) is thought to be a sequential process (vascular, neuronal, and consecutive muscular impairment), but understanding of the underlying histological changes and how they translate to symptoms, is still lacking. Therefore, we systematically investigated histological characteristics of SSc in the intestines, compared to controls.

Methods

Autopsy material from the small bowel and colon was used for histological semiquantitative evaluation of the vasculature, enteric nervous system, interstitial cells of Cajal (ICC), and muscle layers, using a combination of histochemical and immunohistochemical stainings, according to guidelines of the Gastro 2009 International Working Group.

Results

Vascular changes were most frequently encountered, represented by intima fibrosis in both arteries and small vessels, and represented by venous dilatation. Second, generalized fibrosis of the circular muscle layer was significantly more found in SSc patients than in controls. Third, reduction of submucosal nerve fibers and myenteric neurons was shown in the colon of four SSc patients, which may explain severe symptoms of intestinal dysmotility. The density of myenteric ICC network was decreased in the small bowel of SSc patients.

Conclusions

The postulated sequential processes of intestinal involvement in SSc could not be supported by our histological evaluation. The interpatient diversity suggests that parallel processes occur, explaining the variety of histological features and clinical symptoms.
Key Points
• Histological analysis showed vascular changes, fibrosis in the muscularis propria, and reduction of the ENS and ICC network in the intestines of SSc patients.
• Pathophysiological mechanisms leading to intestinal dysmotility in SSc may be parallel rather than sequential.
• The interpatient diversity suggests parallel pathophysiological processes, explaining the variety of histological features and clinical symptoms.
Appendix
Available only for authorised users
Literature
15.
go back to reference Sjolund K, Bartosik I, Lindberg G, Scheja A, Wildt M, Akesson A (2005) Small intestinal manometry in patients with systemic sclerosis. Eur J Gastroenterol Hepatol 17(11):1205–1212CrossRefPubMed Sjolund K, Bartosik I, Lindberg G, Scheja A, Wildt M, Akesson A (2005) Small intestinal manometry in patients with systemic sclerosis. Eur J Gastroenterol Hepatol 17(11):1205–1212CrossRefPubMed
19.
go back to reference Sjogren RW (1994) Gastrointestinal motility disorders in scleroderma. Arthritis Rheum 37(9):1265–1282CrossRefPubMed Sjogren RW (1994) Gastrointestinal motility disorders in scleroderma. Arthritis Rheum 37(9):1265–1282CrossRefPubMed
21.
go back to reference Manetti M, Milia AF, Benelli G, Messerini L, Matucci-Cerinic M, Ibba-Manneschi L (2010) The gastric wall in systemic sclerosis patients: a morphological study. Ital J Anat Embryol 115(1–2):115–121PubMed Manetti M, Milia AF, Benelli G, Messerini L, Matucci-Cerinic M, Ibba-Manneschi L (2010) The gastric wall in systemic sclerosis patients: a morphological study. Ital J Anat Embryol 115(1–2):115–121PubMed
23.
go back to reference Knowles CH, De Giorgio R, Kapur RP, Bruder E, Farrugia G, Geboes K, Gershon MD, Hutson J, Lindberg G, Martin JE, Meier-Ruge WA, Milla PJ, Smith VV, Vandervinden JM, Veress B, Wedel T (2009) Gastrointestinal neuromuscular pathology: guidelines for histological techniques and reporting on behalf of the Gastro 2009 International Working Group. Acta Neuropathol 118(2):271–301. https://doi.org/10.1007/s00401-009-0527-yCrossRefPubMed Knowles CH, De Giorgio R, Kapur RP, Bruder E, Farrugia G, Geboes K, Gershon MD, Hutson J, Lindberg G, Martin JE, Meier-Ruge WA, Milla PJ, Smith VV, Vandervinden JM, Veress B, Wedel T (2009) Gastrointestinal neuromuscular pathology: guidelines for histological techniques and reporting on behalf of the Gastro 2009 International Working Group. Acta Neuropathol 118(2):271–301. https://​doi.​org/​10.​1007/​s00401-009-0527-yCrossRefPubMed
28.
go back to reference Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, Tinevez JY, White DJ, Hartenstein V, Eliceiri K, Tomancak P, Cardona A (2012) Fiji: an open-source platform for biological-image analysis. Nat Methods 9(7):676–682. https://doi.org/10.1038/nmeth.2019CrossRefPubMed Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, Tinevez JY, White DJ, Hartenstein V, Eliceiri K, Tomancak P, Cardona A (2012) Fiji: an open-source platform for biological-image analysis. Nat Methods 9(7):676–682. https://​doi.​org/​10.​1038/​nmeth.​2019CrossRefPubMed
33.
35.
go back to reference Greydanus MP, Camilleri M (1989) Abnormal postcibal antral and small bowel motility due to neuropathy or myopathy in systemic sclerosis. Gastroenterology 96(1):110–115CrossRefPubMed Greydanus MP, Camilleri M (1989) Abnormal postcibal antral and small bowel motility due to neuropathy or myopathy in systemic sclerosis. Gastroenterology 96(1):110–115CrossRefPubMed
Metadata
Title
Intestinal hypomotility in systemic sclerosis: a histological study into the sequence of events
Authors
M. den Braber-Ymker
M. C. Vonk
K. Grünberg
M. Lammens
I. D. Nagtegaal
Publication date
01-03-2021
Publisher
Springer International Publishing
Published in
Clinical Rheumatology / Issue 3/2021
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-020-05325-8

Other articles of this Issue 3/2021

Clinical Rheumatology 3/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.